FCGR3A and neoplasm: Historically, NK cells in human are divided into the cytotoxic CD3−CD56+CD16+ and the IFN-γ producing CD3−CD56+CD16− counterparts, which congruously and spontaneously benefit tumor immunosurveillance and elimination of cancer cells and pathogenic microorganism via natural cytotoxicity effects [1, 6].